Gladwin MT - Search Results

1

Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Kato GJ, Hsieh M, Machado R, Taylor J 6th, Little J, Butman JA, Lehky T, Tisdale J, Gladwin MT. Kato GJ, et al. Among authors: gladwin mt. Am J Hematol. 2006 Jul;81(7):503-10. doi: 10.1002/ajh.20642. Am J Hematol. 2006. PMID: 16755569 Free PMC article.

2

The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment.

Gladwin MT, Schechter AN, Shelhamer JH, Ognibene FP. Gladwin MT, et al. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1368-76. doi: 10.1164/ajrccm.159.5.9810094. Am J Respir Crit Care Med. 1999. PMID: 10228097 Review. No abstract available.

3

Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia.

Gladwin MT, Rodgers GP. Gladwin MT, et al. Lancet. 2000 Apr 29;355(9214):1476-8. doi: 10.1016/S0140-6736(00)02157-7. Lancet. 2000. PMID: 10801164 No abstract available.

4

Nitric oxide therapy in sickle cell disease.

Gladwin MT, Schechter AN. Gladwin MT, et al. Semin Hematol. 2001 Oct;38(4):333-42. doi: 10.1016/s0037-1963(01)90027-7. Semin Hematol. 2001. PMID: 11605168 Review.

5

Nitric oxide transport on sickle cell hemoglobin: where does it bind?

Gladwin MT, Ognibene FP, Shelhamer JH, Pease-Fye ME, Noguchi CT, Rodgers GP, Schechter AN. Gladwin MT, et al. Free Radic Res. 2001 Aug;35(2):175-80. doi: 10.1080/10715760100300721. Free Radic Res. 2001. PMID: 11697198

6

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.

Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, Patel DB, Jankowski MA, Pannell LK, Schechter AN, Rodgers GP. Gladwin MT, et al. Br J Haematol. 2002 Feb;116(2):436-44. doi: 10.1046/j.1365-2141.2002.03274.x. Br J Haematol. 2002. PMID: 11841449 Free article.

7

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT. Reiter CD, et al. Among authors: gladwin mt. Nat Med. 2002 Dec;8(12):1383-9. doi: 10.1038/nm1202-799. Epub 2002 Nov 11. Nat Med. 2002. PMID: 12426562

8

Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd. Gladwin MT, et al. Circulation. 2003 Jan 21;107(2):271-8. doi: 10.1161/01.cir.0000044943.12533.a8. Circulation. 2003. PMID: 12538427 Clinical Trial.

9

An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy.

Reiter CD, Gladwin MT. Reiter CD, et al. Among authors: gladwin mt. Curr Opin Hematol. 2003 Mar;10(2):99-107. doi: 10.1097/00062752-200303000-00001. Curr Opin Hematol. 2003. PMID: 12579034 Review.

10

Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide.

Zuzak KJ, Gladwin MT, Cannon RO 3rd, Levin IW. Zuzak KJ, et al. Among authors: gladwin mt. Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1183-9. doi: 10.1152/ajpheart.00243.2003. Epub 2003 Jun 5. Am J Physiol Heart Circ Physiol. 2003. PMID: 12791593 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters